lal−/− MSCs exhibited lower levels of these TAF markers than those of lal+/+ MSCs (Figure 6), serving as another mechanism to explain why LAL deficiency impairs MSCs′ tumor-stimulating ability. Here, LIPA is linked to neoplasm.